Infor Cloverleaf Suite Supports Medical Device Manufacturers with Real-Time, Trusted Data
NEW YORK – May 8, 2017 – Infor®, a leading provider of beautiful business applications specialized by industry and built for the cloud, today announced Cleveland Medical Devices, Inc. (CleveMed) selection of the Infor Cloverleaf® Integration Suite. CleveMed, a leading provider of home sleep apnea testing (HSAT) solutions, plans to imbed Infor’s solution into their product in order to capitalize on Infor’s speed and development, and make integration of their products as seamless as possible for healthcare organizations. Infor Cloverleaf is a market leading, enterprise-caliber integration engine that facilitates the movement of highly secure data through disparate systems within the healthcare enterprise.
“One of the most important trends in Healthcare today is the movement of care and monitoring into the community and closer to the patient via remote medical devices (IOT) and mobile applications. For this to work well, we also need to efficiently return that data to the healthcare enterprise, securely and at scale,” said Mark Weber, senior vice president, Infor Healthcare. “Today that means having the ability to easily orchestrate that data exchange across a variety paradigms, such as proprietary or standard web service APIs, such as FHIR, and more traditional methods such as HL7v2 so common in legacy systems. We are pleased to work with market leading innovators such as CleveMed to streamline that data exchange across our customer base.”
By imbedding Infor Cloverleaf into its product, CleveMed can utilize like-to-like coupling, their Cloverleaf system to the Cloverleaf system at a healthcare facility, to speed on-boarding and adoption, which can result in greater satisfaction and lower implementation costs.
“Our company’s goal has always been to expand the reach of sleep medicine with technologies that speed diagnosis for providers, reduce healthcare costs for payers, and improve patients’ experiences in the home. Partnering with Infor is what is going to take us to that next step,” said Sarah Weimer, director, Sleep Services and Products, CleveMed. “Infor’s greatest advantage in the market is its customer footprint and reputation, which provides a tremendous advantage for CleveMed to grow our business globally.”
According to HIMSS Analytics, Infor Cloverleaf is the leader in clinical interoperability, and used by more healthcare providers than the next three largest competitors.
“In an era of exceptionally high expectations for medical technology organizations to consistently deliver in the areas of innovation and quality, purchasing a tried and tested interoperability platform from Infor delivers important advantages in terms of cost and market competitiveness. Our company is committed to investing in cloud-based applications that will help medical device companies do business better.” continued Weber.
For more information please visit http://www.infor.com/product-summary/healthcare/cloverleaf/.
Infor builds business software for specific industries in the cloud. With 15,000 employees and over 90,000 customers in more than 170 countries, Infor software is designed for progress. To learn more, please visit www.infor.com.
CleveMed is a fast growing company with a wide range of sleep testing equipment, services, and cloud based technologies that allow sleep disorders to be monitored in the home, including Sapphire PSG™, SleepScout™, SleepView®, SleepViewSM Web-portal, and SleepView Direct. CleveMed’s goal is to expand the reach of sleep medicine with technologies that speed diagnosis for providers, reduce healthcare costs for payers, and improve patients’ experiences in the home. For more information, please visit https://CleveMed.com
This announcement reflects the direction Infor may take with regard to the specific product(s) described herein, all of which is subject to change by Infor in its sole discretion, with or without notice to you. This announcement is not a commitment to you in any way and you should not rely on this document or any of its content in making any decision. Infor is not committing to develop or deliver any specified enhancement, upgrade, product or functionality, even if such is described in this announcement and even if such description is accompanied by words such as “anticipate,” “believe,” “expect,” “intend,” “may,” “plan,” “project,” “predict,” “should,” “will,” and/or similar expressions. Many factors can affect Infor’s product development plans and the nature, content and timing of future product releases, all of which remain in the sole discretion of Infor. This announcement, in whole or in part, may not be incorporated into any contractual agreement with Infor or its subsidiaries or affiliates. Infor expressly disclaims any liability with respect to this announcement.
Copyright ©2017 Infor. All rights reserved. The word and design marks set forth herein are trademarks and/or registered trademarks of Infor and/or related affiliates and subsidiaries. All other trademarks listed herein are the property of their respective owners. www.infor.com.
 HIMSS Analytics, U.S. Acute Market Share with 150+ beds as of Oct. 2016: for ERP, General Ledger, Materials Management, Payroll and Interface Engine systems